12
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Metachromatic Cells and Eosinophils in the Nasal Mucosa and N,N-Dimethylbenzylamine Exposure

, , &
Pages 433-436 | Received 13 Jun 1996, Accepted 05 Sep 1996, Published online: 08 Jul 2009
 

Abstract

Irander K, Ståhlbom B, Welinder H, Åkesson B. Metachromatic cells and eosinophils in the nasal mucosa and N,N-dimethyl-benzylamine exposure. Acta Otolaryngol (Stockh) 1997; 117: 433-436.

Six healthy non-atopic male volunteers participated in a dose-response study of N,N-dimethylbenzylamine (DMBA), which is a reactive chemical used in epoxy systems. The effects on the nasal mucosa after inhalation of 0, 20, 45, 80 and 120 /ig/m3 were studied by means of symptom recordings, acoustic rhinometry, nasal lavages and nasal cytology processed for light microscopy of metachromatic cells (MC) and eosinophils (EOS). Although only minor symptoms were provoked, the numbers of MC and Eos tended to increase in a dose-response fashion after inhalation of the chemical. No signs of degranulation of the cells were found, as the levels of tryptase and eosinophil cationic protein in the nasal lavages remained low at all DMBA exposure levels. We therefore conclude that a reactive chemical such as DMBA can influence MC and Eos in the nasal mucosa even at low dose levels without causing significant clinical symptoms.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.